David Ventura

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Advanced Non Small Cell Lung Cancer

Clinical Practice

Top Venues

Journal of clinical medicine

Cancer imaging : the official publication of the International Cancer Imaging Society

This page only lists publications with an associated author ORCID identifier.

Publications

Dennis Korthals, Michael Bietenbeck, Hilke Könemann, Florian Doldi, David Ventura, Michael Schäfers, Michael Mohr, Julian Wolfes, Felix Konrad Wegner, Ali Yilmaz, Lars Eckardt
Cardiac Sarcoidosis-Diagnostic and Therapeutic Challenges. Journal of clinical medicine 13 (6) (2024)
Dennis Korthals, Michael Bietenbeck, Hilke Könemann, Florian Doldi, David Ventura, Michael Schäfers, Michael Mohr, Julian Wolfes, Felix Konrad Wegner, Ali Yilmaz, Lars Eckardt
Cardiac Sarcoidosis-Diagnostic and Therapeutic Challenges. Journal of clinical medicine 13 (6) (2024)
David Ventura, Philipp Rassek, Philipp Schindler, Burak Han Akkurt, Linus Bredensteiner, Martin Bögemann, Katrin Schlack, Robert Seifert, Michael Schäfers, Wolfgang Roll, Kambiz Rahbar
Early treatment response assessment with [ 177 Lu]PSMA whole-body-scintigraphy compared to interim PSMA-PET. Cancer imaging : the official publication of the International Cancer Imaging Society 24 (1) (2024)
David Ventura, Philipp Schindler, Max Masthoff, Dennis Görlich, Matthias Dittmann, Walter Heindel, Michael Schäfers, Georg Lenz, Eva Wardelmann, Michael Mohr, Peter Kies, Annalen Bleckmann, Wolfgang Roll, Georg Evers
Radiomics of Tumor Heterogeneity in 18 F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer. Cancers 15 (8) (2023)
David Ventura, Philipp Schindler, Max Masthoff, Dennis Görlich, Matthias Dittmann, Walter Heindel, Michael Schäfers, Georg Lenz, Eva Wardelmann, Michael Mohr, Peter Kies, Annalen Bleckmann, Wolfgang Roll, Georg Evers
Radiomics of Tumor Heterogeneity in 18 F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer. Cancers 15 (8) (2023)